Security key
52187K101
- Security type / class
- Equity / COM
- Total 13F shares
- 42,893,823
- Total 13F value
- $138,979,388
- Share change
- -533,211
- Put/Call ratio
- 19%
- SEC-reported price per share
- $3.24
- Number of holders
- 74
- Value change
- -$9,037,932
- Number of buys
- 46
- Number of sells
- 26
Open additional details 1 more signal available
Report period
Q4 2021
Institutions
74
Top holders
10
LPTX full security history
Ownership snapshot
Full 13F holder table
CYPHERPUNK TECHNOLOGIES INC. SEC filings
CYPHERPUNK TECHNOLOGIES INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of LPTX - LEAP THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
0/15
Latest evidence
30 Sep 2021
13F
3/4/5
Highest disclosed value: $33,990,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $33.99M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Disclosed position value
Top 5
PERCEPTIVE ADVISORS LLC
$33.99M
BeOne Medicines Ltd.
$20.94M
Artal Group S.A.
$16.04M
DEERFIELD MANAGEMENT COMPANY, L.P.
$16.04M
Rock Springs Capital Management LP
$14.07M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
3/4/5
Company · 10%+ Owner
|
—
denominator unverified
|
$33,990,000
8,476,496 shares
|
— | 30 Sep 2021 |
| BeOne Medicines Ltd. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$20,943,045
7,348,437 shares
|
— | 24 Sep 2021 |
| Artal Group S.A. |
13F
Company
|
—
denominator unverified
|
$16,040,000
4,000,000 shares
|
— | 30 Sep 2021 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
—
denominator unverified
|
$16,040,000
4,000,000 shares
|
— | 30 Sep 2021 |
| Rock Springs Capital Management LP |
13F
Company
|
—
denominator unverified
|
$14,068,000
3,508,270 shares
|
— | 30 Sep 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$10,837,000
2,702,625 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
74
Shares
42,893,823
Rows available
74
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
62
Q4 2021 holders
74
Holder diff
12
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|